Virginie Chesnais

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

Frédérik Damm, Olivier Kosmider, Véronique Gelsi‐Boyer et al. · Blood · 2012 · 230 citations

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

Frédérik Damm, Virginie Chesnais, Yasunobu Nagata et al. · Blood · 2013 · 215 citations

Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse et al. · Cell · 2021 · 199 citations · Full text

Vaccination, Mucosal Vaccination, Cross-protection +12

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells

Laury Poulain, Pierre Sujobert, Florence Zylbersztejn et al. · Leukemia · 2017 · 140 citations

Hematological Malignancy, Molecular Pharmacology, G6pd Inhibition +9

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

Pauline Maisonnasse, Yoann Aldon, Aurélien Marc et al. · Nature Communications · 2021 · 54 citations · Full text